We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
6 June
- Regulatory update from the Complementary and Over-the-Counter Medicines Branch
- Appealing TGA Decisions and Navigating Section 60 Reviews for Devices and Medicines
- Impact of European IVD Regulations in Australia
- Regulation of cell and gene therapies in Australia
- Recall reforms
- New substance applications to vary the permissible ingredients determination
- Streamlining the development of prescription medicines: Peptides to biosimilars to GMOs
- Learnings and best practices for compliance with 'patient-matched' devices
- Good Manufacturing Practice compliance signals
- Systematic literature reviews for OTC and complementary medicines
- Emerging medical device technologies and use of real-world data
7 June
- An update on clinical evidence guidelines for medical devices
- Hot topics in prescription medicines
- Regulatory update from the Medical Devices Authorisation Branch
- Lapses in conformity assessment
- Reclassification of some medical devices
- Update from the Prescription Medicines Authorisation Branch
- Medicine labelling: Update on the implementation of TGO91 / 92
- Update from the Pharmacovigilance Branch
- Sharing adverse event data for medicines and vaccines
- Updates on clinical trial inspections and the CTA scheme
- Regulatory update from the Medical Devices Surveillance Branch
- Transitioning from provisional to full approval